Sutro Biopharma

Sutro Biopharma: Clinical-stage oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs). Sutro has two wholly owned ADCs in the clinic—STRO-002, a folate receptor alpha (FolRα)-targeting ADC, in clinical studies for ovarian and endometrial cancers; and STRO-001, a CD74-targeting ADC, in clinical studies for B-cell malignancies. STRO-003, an optimally designed ROR1-targeting ADC, is anticipated to be the next proprietary product candidate to move into clinical studies. Sutro also has high value collaborations with BMS (BCMA ADC), Merck (cytokine derivatives), EMD Serono (MUC1-EGFR bispecific ADC), and Astellas (immunostimulatory antibody-drug conjugates or iADCs).
Based in...
US - Pacific
Clinical Stage
Phase l or ll
Disease Space
Autoimmune, Infectious Disease, Oncology
Public, USA
Market Cap
100MM - 500MM
Therapeutic Modalities
Antibodies, Platform Technology
111 Oyster Point Blvd
South San Francisco, CA 94080
United States

Company Participants at Solebury 1x1 Management Access Event 2023

  • Bill Newell, Chief Executive Officer
  • Trevor Hallam, Ph.D., Chief Scientific Officer

Top 10 Holders of Sutro Biopharma, Inc.

Institution OS (%) Position Mkt Val ($MM) Source Filing Date
Suvretta Capital Management LLC 9.90 5,689,086 26.85 13F 3/31/23
Rubric Capital Management LP 7.59 4,360,487 20.58 13F 3/31/23
BVF, Inc. 5.83 3,347,946 15.80 13F 3/31/23
State Street Corp. 5.09 2,922,712 13.80 13F 3/31/23
Franklin Advisers, Inc. 4.90 2,815,577 13.29 13F 3/31/23
The Vanguard Group, Inc. 4.58 2,751,252 12.99 Funds 4/30/23
Vanguard Group, Inc. (Subfiler) 4.74 2,722,697 12.85 13F 3/31/23
Candriam Belgium SA 4.64 2,668,550 12.60 Funds 12/30/22
BlackRock Fund Advisors 3.93 2,260,921 10.67 13F 3/31/23
Holocene Advisors, LP 3.71 2,132,873 10.07 13F 3/31/23
Ownership data is sourced through FactSet.

Stock Market Data

Data is being loaded...
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2023 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, RTB=Real-Time BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.